ResMed CEO Mick Farrell will ring the opening bell at the New York Stock Exchange on Monday, Sept. 30, 2019, to celebrate 20 years of being listed on the New York Stock Exchange and to commemorate ResMed’s 30th anniversary.
Farrell will be joined on the bell podium with other members of the ResMed management team, according to a statement from the company.
Founded in 1989, ResMed began as ResCare, a management buy-out of sleep apnea technology from Baxter Healthcare. Today, ResMed is a software-driven medical device company with over 4.5 billion nights of medical sleep and respiratory care data and over 10 million 100% cloud connectable medical devices in the market.
“From a single $1.25 million investment, ResMed has transformed into a $28 billion (US$19 billion) connected health leader, changing over 100 million lives a year with either a cloud-connected medical device or through software support of an out-of-hospital care agency,” says Farrell in a statement.
“I’m proud to be one of 7,500-plus ResMedians worldwide dedicated to improving the quality of so many lives, and one of countless investors who have long seen and supported the value of all that ResMed creates. And we are just getting started.”